Grifols Deutschland GmbH
Grifols Alemania se creó en 1997. Desde las oficinas de Frankfurt, gestionamos la comercialización de Bioscience en el mercado nacional y la de Diagnostic en los mercados alemán, austríaco y suizo (DACH).
Ofrecemos un amplio catálogo de productos y servicios de las divisiones Bioscience y Diagnostic. La seguridad y la calidad son una prioridad a la hora de desarrollar nuestra misión: mejorar la salud y el bienestar de las personas en todo el mundo.
Colmarer Strasse 22
60528 Frankfurt am Main
Germany
Información de contacto
Tel: (49) (69) 660593 100
Fax: (49) (69) 660593 110
Contacta con Grifols
Gracias por contactar con nosotros. Le responderemos tan pronto como sea posible.
ACEPTARLe agradecemos su interés en conocernos mejor. Responderemos a sus preguntas tan pronto sea posible. Por favor, complete todos los campos requeridos, ya que nos permitirá procesar su solicitud de manera más eficiente. La compañía identificada en esta sección es el responsable del tratamiento de sus datos y tratará sus datos personales porque usted ha otorgado su consentimiento al completar este formulario. Puede ejercer sus derechos de acceso, rectificación, supresión y otros derechos de protección de datos, así como obtener información adicional respecto al tratamiento de sus datos en la Política de Privacidad
Transparency
Industry interactions with the medical profession have a profound and positive influence patient treatment and on the value of research. As primary providers of healthcare services, both healthcare professionals and healthcare organizations, offer us unique, independent insights and expert knowledge on patients' behavior and management of diseases. The capacity of gaining access to this expertise, plays a critical role in informing and guiding industry efforts to improve the quality of patient care and treatment options. And this is why, both healthcare professionals and healthcare organizations, should be fairly compensated for their contributions, as well as for the services they provide to the industry.
Industry interactions with healthcare professionals and healthcare organizations, should not only be conducted with integrity, but should also be transparent. And this is why Grifols Group fully supports, and has voluntarily adopted, the practices reflected in the new EFPIA Disclosure Code, and will continue to support any other country codes which promulgate transparency reporting.
To the above extent, Grifols Deutschland, as member of the AKG e.V. (Arzneimittel und Kooperation im Gesundheitswesen e.V.) is fully supportive of a transparent documentation of all collaborations with healthcare professionals and healthcare organizations, and has adopted the transparency guideline contained in the AKG Code of Conduct. Based on this guideline, Grifols Deutschland publishes, within a publicly available list, all its interactions with German-based healthcare professionals and healthcare organizations.
Per instructions from AKG e.V., these interactions have been split into 4 categories: (a) Research and Development; (b) Donations; (c) Sponsoring of Educational Events; and (d) Honoraria for Services. Interactions within the category "Research and Development" will be published in an aggregate format. In the other categories, interactions will be published in an individual format, in so far as permitted under German legal requirements on personal data protection.
Commitment to patients
Every day at Grifols, patients inspire our mission to advance the discovery and development of innovative protein therapies that extend and enhance lives. We continually strive to develop new and better products and services to improve our patients' health and well being. To further our mission, Grifols Germany actively supports patient organizations, programs and services that promote education, disease awareness, and patient advocacy efforts in order to improve the diagnosis and treatment of disease.